VitroGel® RGD enhances stem cell transplantation to treat intervertebral disc degeneration using rat models, laying new foundations in the movement toward cell-based tissue therapies. Institution: Dalian Medical University, Clinical Medical College of Yangzhou University Team: Feng Wang, Li-ping Nan, Shi-feng Zhou, Yang Liu, Ze-yu Wang, Jing-cheng Wang, Xin-min Feng *, and Liang Zhang Application: 3D […]
Author Archives: thewellbio
In vitro three-dimensional culture of murine ovarian follicles in the VitroGel demonstrates superior morphology and growth compared to other biomaterials and 2D culture. Institution: Seoul National University, Eulji University Team: Eun Jung Kim, Chungmo Yang, Jaewang Lee, Hye Won Youm, Jung Ryeol Lee *, Chang Suk Suh, Seok Hyun Kim Application: 3D follicle culture Disease […]
Manipulation of the adenosine metabolite ADK-L may offer a way to modulate cell invasion and proliferation of breast cancer cells, offering a possible therapeutic solution to aggressive breast cancers. Institution: Legacy Research Institute, Mid-Columbia Medical Center Team: Bahar Shamloo*, Nandita Kumar, Randall H. Owen, Jesica Reemmer, John Ost, R. Serene Perkins, and Hai-Ying Shen* Application: […]
We are excited to be a part of the ARMI BioFabUSA program. We look forward to the collaborations to help ARMI’s mission to make practical the large-scale manufacturing of engineered tissues and tissue-related technologies, to benefit existing industries and grow new ones. “TheWell Bioscience Inc., a New Jersey biotech company focused on 3D cell culture, […]
North Brunswick, NJ., January 16, 2020 – TheWell Bioscience Inc, a biotech company focusing on 3D cell culture, launches VitroINK™, a new series of xeno-free tunable bioink system that requires no UV, no temperature/pH curing or chemical crosslinking. The new bioinks are ready-to-use at room temperature, have excellent visibility after printing, and can incorporate multiple […]
Cancer cell-derived and plasma-derived oncogenic extracellular vesicles uniquely carry the cell cycle activator c-Myc and promote cell cycle upregulation and cluster formation of healthy cells in a 3D microenvironment. Institution: Fondazione IRCCS Istituto Nazionale dei Tumori, Istituto di scienze e tecnologie Molecolari CNR Team: Cristina Borzi, Linda Calzolari, Anna M. Ferretti, Laura Caleca, Ugo Pastorino, […]
Introducing OSA 1777, a cell line derived from recurring osteosarcoma, which unlike existing cell lines, forms spheroids in 3D culture reminiscent of osteosarcoma tumors. Institution: David Geffen School of Medicine, University of California, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Chinese Academy of Medical Sciences and Peking Union Medical College Team: Pichaya […]
New mechanistic insights into the tumorigenesis of DIPG yield a novel potential treatment: PPM1D inhibitors Institution: Emory School of Medicine Team: Mwangala Precious Akamandisa, Kai Nie, Rita Nahta, Dolores Hambardzumyan, and Robert Craig Castellino * Application: Use of VitroGel 3D for in vivo studies and assessing cell survival Disease model: Diffuse intrinsic pontine glioma (DIPG) […]
Our team is excited to exhibit at this year’s ASCB 2019 in Washington, D.C. We will showcase new VitroGel hydrogels as well as our new VitroINK bioink for 3D bioprinting. If attending, stop by booth 520 to learn about our advanced hydrogel system for 3D cell culture, 3D bioprinting, tissue engineering, drug screening, and cell […]
To receive more information on this poster, please fill the form.